Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Acq. announced
Disc Medicine, Inc. Create: Alert

All | News | Filings
Date FiledTypeDescription
10/10/2023 8-K Quarterly results
10/10/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
09/29/2023 8-K Termination of a Material Definitive Agreement  Interactive Data
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/15/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 144 Form 144 - Report of proposed sale of securities:
08/11/2023 8-K Quarterly results
08/11/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/01/2023 144 Form 144 - Report of proposed sale of securities:
06/30/2023 SC 13G ADAGE CAPITAL PARTNERS GP, L.L.C. reports a 5.2% stake in Disc Medicine, Inc.
06/30/2023 144 Form 144 - Report of proposed sale of securities:
06/29/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 SC 13G/A Novo Holdings A/S reports a 4.8% stake in Disc Medicine, Inc.
06/28/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 144 Form 144 - Report of proposed sale of securities:
06/28/2023 144 Form 144 - Report of proposed sale of securities:
06/16/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549",
"Underwriting Agreement, by and among the Company and Morgan Stanley & Co. LLC, SVB Securities LLC, Stifel, Nicolaus & Company, Incorporated, and BMO Capital Markets Corp., as representatives of the several underwriters listed on Schedule A thereto",
"Form of Pre-Funded Warrant",
"Opinion of Goodwin Procter LLP regarding the issue of Common Stock, Pre-Funded Warrants and Common Stock issuable upon exercise of the Pre-Funded Warrants being registered",
"Disc Medicine Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants",
"Disc Medicine Announces Pricing of Upsized Public Offering of Common Stock and Pre-Funded Warrants"
06/12/2023 8-K Other Events  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
06/12/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
Docs: "UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549"
06/09/2023 8-K Investor presentation
Docs: "Disc Presents Positive Initial Data from Phase 2 BEACON Trial of Bitopertin in Patients with Erythropoietic Protoporphyria at European Hematology Association 2023 Congress",
"Disc Medicine, Inc. Investor Presentation, furnished herewith"
05/15/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/15/2023 8-K Quarterly results
Docs: "Disc Medicine Reports First Quarter 2023 Financial Results and Provides Business Update"
04/20/2023 ARS Form ARS - Annual Report to Security Holders:
04/20/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/20/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
04/19/2023 8-K Quarterly results
03/31/2023 10-K Annual Report for the period ended December 31, 2022
03/31/2023 8-K Quarterly results
02/24/2023 SC 13G Bain Capital Life Sciences Opportunities III, LP reports a 10% stake in Disc Medicine, Inc.
02/14/2023 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy